Filed: 5/15/2023ACC: 0001104659-23-060321
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 18 equity positions with a total reported market value of $133.89M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
18
Positions
$133.89M
Total AUM (reported)
7.38M
Total Shares
Allocation by class
COMMON$114.78M85.7%
SHS$10.83M8.1%
SPONSORED ADR$8.28M6.2%
Portfolio Concentration
Top 3$37.84M28.3%
4–10$67.28M50.3%
11–25$28.76M21.5%
Top 3 weight
28.3%
Top 10 weight
78.5%
Voting Authority Distribution
Total shares with voting rights: 7.38M
Sole
Full voting authority
7.38M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole18
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings18
Rows:
CYMABAY THERAPEUTICS INC
SOLEShares1.63M
TypeSH
Market value$14.21M
10.61%
Sole
1.63M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares741.04K
TypeSH
Market value$11.90M
8.89%
Sole
741.04K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares506.82K
TypeSH
Market value$11.73M
8.76%
Sole
506.82K
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PLC
SOLEShares99.22K
TypeSH
Market value$10.83M
8.09%
Sole
99.22K
Shared
0.00
None
0.00
BIOGEN INC(NSM)
SOLEShares37.46K
TypeSH
Market value$10.41M
7.78%
Sole
37.46K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares282.89K
TypeSH
Market value$9.95M
7.44%
Sole
282.89K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.16M
TypeSH
Market value$9.70M
7.25%
Sole
1.16M
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares246.62K
TypeSH
Market value$9.28M
6.93%
Sole
246.62K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.12M
TypeSH
Market value$8.82M
6.59%
Sole
1.12M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S - ADR
SOLEShares77.21K
TypeSH
Market value$8.28M
6.18%
Sole
77.21K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares123.17K
TypeSH
Market value$8.12M
6.07%
Sole
123.17K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares480.65K
TypeSH
Market value$6.54M
4.89%
Sole
480.65K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares145.02K
TypeSH
Market value$6.08M
4.54%
Sole
145.02K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC(NMS)
SOLEShares258.29K
TypeSH
Market value$2.86M
2.14%
Sole
258.29K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares178.22K
TypeSH
Market value$1.96M
1.46%
Sole
178.22K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares172.19K
TypeSH
Market value$1.76M
1.31%
Sole
172.19K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares101.34K
TypeSH
Market value$1.35M
1.01%
Sole
101.34K
Shared
0.00
None
0.00
SCILEX HOLDING CO(NAS)
SOLEShares10.39K
TypeSH
Market value$85.2K
0.06%
Sole
10.39K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYMABAY THERAPEUTICS INCSOLE | Common | 1.63M | SH | $14.21M 10.61% | 1.63M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | Common | 741.04K | SH | $11.90M 8.89% | 741.04K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | Common | 506.82K | SH | $11.73M 8.76% | 506.82K | 0.00 | 0.00 |
HORIZON THERAPEUTICS PLCSOLE | SHS | 99.22K | SH | $10.83M 8.09% | 99.22K | 0.00 | 0.00 |
BIOGEN INC(NSM)SOLE | Common | 37.46K | SH | $10.41M 7.78% | 37.46K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | Common | 282.89K | SH | $9.95M 7.44% | 282.89K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | Common | 1.16M | SH | $9.70M 7.25% | 1.16M | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | Common | 246.62K | SH | $9.28M 6.93% | 246.62K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | Common | 1.12M | SH | $8.82M 6.59% | 1.12M | 0.00 | 0.00 |
ASCENDIS PHARMA A/S - ADRSOLE | Sponsored ADR | 77.21K | SH | $8.28M 6.18% | 77.21K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | Common | 123.17K | SH | $8.12M 6.07% | 123.17K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | Common | 480.65K | SH | $6.54M 4.89% | 480.65K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | Common | 145.02K | SH | $6.08M 4.54% | 145.02K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INC(NMS)SOLE | Common | 258.29K | SH | $2.86M 2.14% | 258.29K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | Common | 178.22K | SH | $1.96M 1.46% | 178.22K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | Common | 172.19K | SH | $1.76M 1.31% | 172.19K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | Common | 101.34K | SH | $1.35M 1.01% | 101.34K | 0.00 | 0.00 |
SCILEX HOLDING CO(NAS)SOLE | Common | 10.39K | SH | $85.2K 0.06% | 10.39K | 0.00 | 0.00 |